Skip to main content

Featured

New Guidance Says Doctors Should Discuss Vaping as One Option to Help Adults Quit Smoking

Quitting smoking is one of the best things a person can do for their health—but it's also one of the hardest habits to break. Many smokers make several attempts before they successfully quit, even when using medications or nicotine replacement products. Now, a panel of tobacco treatment experts is encouraging healthcare providers to expand the conversation about smoking cessation by discussing nicotine e-cigarettes as one possible option for adults who smoke cigarettes. The recommendations, published in JAMA , were developed by the Harm Reduction Work Group of the Society for Research on Nicotine and Tobacco’s Treatment Research Network. Rather than promoting vaping, the group says clinicians should focus on helping patients choose the quit-smoking method that best fits their individual circumstances. A Personalized Approach to Quitting Smoking cessation isn't the same for everyone. What works well for one person may not work for another, which is why the authors recommend mo...

Senate report cites previously known Avandia heart risks and other briefs

Avandia dangers to the heart cited in Senate report 

The FDA has recently issued strong warnings about the risk of heart attack from taking drugs used to treat diabetes, including Avandia. Those warnings have existed for several years. Diabetics are already at higher risk for heart attack and heart disease because diabetes causes a lack of typical warning signs of a heart attack. A Senate report cites the heart dangers of Avandia that including heart attack and heart failure.

An enzyme found that keeps the heart healthy The enzyme calcineurin has been identified by researchers as a critical player in keeping the heart healthy as well as for normal heart development. In mouse studies, the enzyme was found to play a critical role in maintaining the strength of heart contractions and normal heart rhythm. 

Marijuana for pain treatment found in first clinical trials in two decades Researchers from California's Center for Medicinal Cannabis Research (CMCR) today presented findings to the California legislature and the public that smoking marijuana has therapeutic value for treating specific pain-related conditions. The studies are the first conducted on the therapeutic value of smoked cannabis in the US in more than twenty years. 

Comments